*Department of Neurology and Psychiatry
†Taub Institute for Research on Alzheimer’s Disease and the Aging Brain
§Division of Geriatric Psychiatry, New York State Psychiatric Institute
∥Columbia University Medical Center, New York, NY
Supported by R01AG047146 from the National Institute of Aging. D.P.D. receives research support from the NIH. He received compensation from Lundbeck and Astellas and AbbVie on scientific advisory committees and from Intracellular Therapeutics as a consultant. He receives research support from Avanir. He has no financial conflicts of interest with the presented work. W.C.K. has received support from Merck, AstraZeneca, and the National Institute on Aging. He has no financial conflicts of interest with the presented work. K.M. receives research support from the NIH, 1UL1 RR024156-01(Director PCIR), PO412196- G (Co-I), and PO412196-G (Co-I). She received compensation for participating on the steering committee for U01NS052592 and from the Parkinson Disease Foundation, Huntington’s Disease Society of America, CHDI, and the Michael J Fox foundation. She receives research support from TEVA and Vaccinex. She serves on scientific advisory committee for Raptor Pharmaceuticals. She has no financial conflicts of interest with the presented work. E.D.H. receives research support from NIH/NINDS grants R00NS060766 and R01NS076837, and the Irving Institute of Columbia University. He has no financial conflicts of interest with the presented work. The remaining authors declare no conflicts of interest.
Reprints: Davangere P. Devanand, MD, 1051 Riverside Drive, Unit 126, New York, NY 10032 (e-mail: email@example.com).
Received April 22, 2016
Accepted June 25, 2016